Connecticut’s Medicaid spending per enrollee jumped 14% between 2023 and 2024, nearly doubling the per-person cost growth of health expenses in the state overall, according to an April 2026 report by the state Office of Health Strategy. Despite the increase, Medicaid, known as HUSKY in Connecticut, still managed to maintain the lowest costs per enrollee […]
Already a Subscriber? Log in
Get Instant Access to This Article
Subscribe to Hartford Business Journal and get immediate access to all of our subscriber-only content and much more.
- Critical Hartford and Connecticut business news updated daily.
- Immediate access to all subscriber-only content on our website.
- Bi-weekly print or digital editions of our award-winning publication.
- Special bonus issues like the Hartford Book of Lists.
- Exclusive ticket prize draws for our in-person events.
Click here to purchase a paywall bypass link for this article.
Connecticut’s Medicaid spending per enrollee jumped 14% between 2023 and 2024, nearly doubling the per-person cost growth of health expenses in the state overall, according to an April 2026 report by the state Office of Health Strategy.
Despite the increase, Medicaid, known as HUSKY in Connecticut, still managed to maintain the lowest costs per enrollee of any market — even when compared to commercial insurance.
“Medicaid is still far and away the cheapest program, and it has way sicker people overall than commercial [insurance],” said Sheldon Toubman, an attorney with Disability Rights Connecticut.
Retail pharmacy and long-term care services were the biggest drivers in the Medicaid cost increases, said Alexander Reger during a presentation of the results on Tuesday. Reger was, at the time of the presentation, healthcare benchmarks initiative director for the state Office of Health Strategy (OHS dissolved as of the close of business on June 25. Its staff and core operations have been transferred to other departments).
In recent years, the Medicaid program has come under fire for cost overruns. But Sen. Matt Lesser, D-Middletown, said those criticisms are more around budgeting than about underlying costs.
In fact, many Democratic lawmakers are calling for increases in investments to the Medicaid program, particularly in the wake of pending federal work requirements that could jeopardize coverage for more than 100,000 residents currently enrolled in the program.
For years, physicians and legislators on both sides of the aisle have been sounding the alarm that the state doesn’t pay providers enough to treat patients with Medicaid coverage, thus decreasing access to care for those residents. Over the past two years, lawmakers have voted to pass a net increase of $50 million for Medicaid reimbursement rates in fiscal year 2027 compared to FY 2025.
“Those changes to the rate structure are also going to increase costs. And they’re designed to. That’s literally what we’re setting out to do as a policy,” Lesser said.
But while many lawmakers agree that increased investments in Medicaid are necessary, Lesser said there are areas, like pharmaceutical spending, where state officials are working to control program costs.
The Department of Social Services was not able to comment in time for publication.
